Acrivon Therapeutics, Inc.
ACRV
Revenue
0.00
0.000.00%
-Assets
196.59M
▼-18.10M▼-8.43%
3 Months ChangeLiabilities
19.80M
▲2.01M▲11.30%
3 Months ChangeFree Cash Flow
-17.90M
▼-6.52M▼-57.25%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-11
Form 8-K
ID: 0000950170-24-114213
2024-09-16
Form 8-K
ID: 0001193125-24-219180
2024-08-13
Form 8-K
ID: 0000950170-24-095766
2024-08-13
Form 10-Q
ID: 0000950170-24-095760
2024-06-21
Form 8-K
ID: 0000950170-24-075760
2024-05-14
Form 8-K
ID: 0000950170-24-059097
2024-05-14
Form 10-Q
ID: 0000950170-24-059084
2024-04-24
Form 8-K
ID: 0000950170-24-047560
2024-04-09
Form 8-K
ID: 0000950170-24-042789
2024-03-28
Form 8-K
ID: 0000950170-24-037627